What causes autism? Exploring the environmental contribution

Current Opinion in Pediatrics

Volumn 22, Issue 2, 2010, Pages 219-225

  Landrigan, Philip J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Developmental neurotoxicity; National children's study; Toxicity testing; Vaccines

Indexed keywords

ALCOHOL; ARSENIC; CHLORPHENOTANE; CHLORPYRIFOS; LEAD; MANGANESE; MEASLES MUMPS RUBELLA VACCINE; METHYLMERCURY; MISOPROSTOL; ORGANOPHOSPHATE INSECTICIDE; POLYCHLORINATED BIPHENYL; THALIDOMIDE; THIOMERSAL; VALPROIC ACID;

AUTISM; BRAIN DEVELOPMENT; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FIRST TRIMESTER PREGNANCY; HEREDITY; HUMAN; IMMUNIZATION; INTERDISCIPLINARY COMMUNICATION; MATERNAL DISEASE; NERVE CELL DIFFERENTIATION; NEUROBIOLOGY; NEUROTOXICITY; PRENATAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RUBELLA; TOXICITY TESTING;

ADULT; AUTISTIC DISORDER; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 77952258327     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328336eb9a     Document Type: Review

References (82)

1. Kanner L. Autistic disturbance of affective contact. Nerv Child 1943;2:217-250.
2. American Academy of Pediatrics. Committee on Children with Disabilities. The pediatrician's role in the diagnosis and management of autistic spectrum disorder in children. Pediatrics 2000;107:1221-1226.
3. Rapin I. The autistic-spectrum disorder. N Engl J Med 2002;347:302-303.
4. Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63-77.
5. Monaco AP, Bailey AJ. The search for susceptibility genes. Lancet 2001; 358: S3.
6. Hultman CM, Sparén P, Cnattingius S. Perinatal risk factors for infantile autism. Epidemiology 2002;13:417-423. (Pubitemid 34627840)
7. Daniels JL. Autism and the environment. Environ Health Perspect 2006; 114: A396.
8. Institute of Medicine. Autism and the environment: opportunities and challenges for research. Washington: National Academies Press; 2008. A scholarly report on a 2007 forum convened by the Institute of Medicine to examine the interplay of environmental and genetic factors in causation of autism. It proposes a framework for a research agenda.
9. Sutcliffe JS. Genetics. Insights into the pathogenesis of autism. Science 2008;321:208-209.
10. Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorders: autism and developmental disabilities monitoring network, six sites, United States, 2000. MMWRSurveillSumm 2007;56:1-11.
11. Fombonne E. The prevalence of autism. J Am Med Assoc 2003;289:87-90. (Pubitemid 36026283)
12. Rutter M. Incidence of autism spectrum disorders: changes over time and their meaning. Acta Paediatr 2005;94:2-15. (Pubitemid 40127925)
13. Murphy M, Bolton PF, Pickles A, et al. Personality traits of the relatives of autistic probands. Psychol Med 2000;30:1411-1424.
14. Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry 2005; 66 (Suppl 10) : 3-8. (Pubitemid 43133208)
15. Folstein SE, Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet 2001;2:943-955. (Pubitemid 33691091)
16. Barton M, Volkmar F. How commonly are known medical conditions associated with autism? J Autism Dev Disord 1998;28:273-278. (Pubitemid 28368954)
17. Zoghbi HY. MeCP2 dysfunction in humans and mice. J Child Neurol 2005;20:736-740.
18. Lamb JA, Parr JR, Bailey AJ, et al. Autism: in search of susceptibility genes. Neuromolecular Med 2002;2:11-28.
19. Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics 2004; 113: e472-e486.
20. Santangelo SL, Tsatsanis K. What is known about autism: genes, brain, and behaviour. Am J Pharmacogenomics 2005;5:71-92.
21. Autism Genome Project Consortium, Szatmari P, Paterson AD, Zwaigenbaum L, et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007;39:319-328. (Pubitemid 46328498)
22. Kumar RA, KaraMohamed S, Sudi J, et al. Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 2008;17:628-638. (Pubitemid 351201774)
23. Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11 and autism. N Engl J Med 2008;358:667-675. A study utilizing genotype data from 751 multiplex families with autism to identify recurrent CNVs possibly linked to autism. The researchers identified a novel, recurrent microdeletion and a reciprocal microduplication which were associated with a substantial susceptibility to autism and reportedly account for approximately 1% of ASD cases. (Pubitemid 351240746)
24. Mehler MF. Epigenetics and the nervous system. Ann Neurol 2008;64:602-617. An overview of epigenetics, the applicability of this field to medicine, and a discussion of possible therapeutics to promote disease prevention and recovery related to neurological disorders, including autism.
25. National Academy of Sciences. Developmental neurotoxicology. Washington, DC: National Academic Press; 2002.
26. Gibson JL. A plea for painted railing and painted walls of rooms as the source of lead poisoning among Queensland children. Aust Med Gazette 1904;23:149-153.
27. Harada M. Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol 1995;25:1-24.
28. Landrigan PJ, Whitworth RH, Baloh RW, et al. Neuropsychological dysfunction in children with chronic low-level lead absorption. Lancet 1975;1:708-712.
29. Needleman HL, Gunnoe C, Leviton A, et al. Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med 1979;300:689-695. (Pubitemid 9154804)
30. Canfield RL, Henderson CR Jr, Cory-Sechta DA, et al. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 2003;348:1517-1526.
31. Grandjean P, Perez M. Developmental neurotoxicity: implications of methylmercury research. Int J Environment Health 2008; 2 (3-4) : 417-428.
32. National Academy of Sciences. Pesticides in the diets of infants and children. Washington, DC: National Academy Press; 1993.
33. Grandjean P, Landrigan PJ. Developmental neurotoxicity of industrial chemicals: a silent pandemic. Lancet 2006;368:2167-2178.
34. Rodier PM. Developing brain as a target of toxicity. Environ Health Perspect 1995; 103 (Suppl 6) : 73-76.
35. Rice D, Barone S Jr. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 2000; 108 (Suppl 3) : 511-533. (Pubitemid 30466179)
36. Ginsberg G, Hattis D, Sonawane B. Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants. Toxicol Appl Pharmacol 2004;198:164-183. (Pubitemid 38952834)
37. Jacobson JL, Jacobson SW, Humphrey HEB. Effect of in utero exposure to polychlorinated biphenyls and related contaminants on cognitive functioning in young children. J Pediatr 1990;116:38-45.
38. Jacobson JL, Jacobson SW. Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N Engl J Med 1996;335:783-789.
39. Yamashita N, Doi M, Nishio M, et al. Recent observations of Kyoto children poisoned by arsenic tainted 'Morinaga dry milk' [in Japanese]. Jap J Hyg 1972;27:364-399.
40. Wasserman GA, Liu X, Parvez F, et al. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect 2004;112:1329-1333. (Pubitemid 39294973)
41. Wasserman GA, Liu X, Parvez F, et al. Water manganese exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect 2006;114:124-129. (Pubitemid 43056879)
42. Berkowitz GS, Wetmur JG, Birman-Deych E, et al. In utero pesticide exposure, maternal paraoxonase activity, and head circumference. Environ Health Perspect 2004;112:388-391. (Pubitemid 38351405)
43. Whyatt RM, Rauh V, Barr DB, et al. Prenatal insecticide exposures and birth weight and length among an urban minority cohort. Environ Health Perspect 2004;112:1125-1132. (Pubitemid 39029170)
44. Eskenazi B, Marks AR, Bradman A, et al. Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children. Environ Health Perspect 2007;115:792-798. (Pubitemid 46785051)
45. Eskenazi B, Rosas LG, Marks AR, et al. Pesticide toxicity and the developing brain. Basic Clin Pharmacol Toxicol 2008;102:228-236. This study reports findings from a prospective, birth cohort epidemiological study in California. It finds that prenatal exposure to DDT is associated with impairments in neurobehavioral development. It finds also that prenatal exposure to organophosphate pesticides is linked to PDD, a finding that confirms the observation of Rauh et al. [62]. (Pubitemid 351143428)
46. Grandjean P, Harari R, Barr DB, et al. Pesticide exposure and stunting as independent predictors of neurobehavioral deficits in Ecuadorian school children. Pediatrics 2006; 117: e546-e556. (Pubitemid 46063195)
47. Eskenazi B, Marks AR, Bradman A, et al. In utero exposure to dichlorodiphenyltrichloroethane (DDT) and dichlorodiphenyldichloroethylene (DDE) and neurodevelopment among young Mexican American children. Pediatrics 2006;118:233-241. (Pubitemid 46071167)
48. Streissguth AP, Barr HM, Sampson PD. Moderate prenatal alcohol exposure: effects on child IQ and learning problems at age 7 1/2 years. Alcohol Clin Exp Res 1990;14:662-669.
49. US Environmental Protection Agency. Toxic Release Inventory (TRI) Program. Washington, DC. http://www.epa.gov/tri/tridata/tri06/index.htm. [Accessed 12 December 2008]
50. Centers for Disease Control and Prevention. National Biomonitoring Program. Atlanta: CDC, 2005. http://www.cdc.gov/biomonitoring/. [Accessed 12 December 2008]
51. Goldman LR. Chemicals and children's environment: what we don't know about risks. Environ Health Perspect 1998; 106 (Suppl 3) : 875-880.
52. Rodier PM. Converging evidence for brain stem injury in autism. Dev Psychopathol 2002;14:537-557.
53. Stromland V, Nordin M, Miller B, et al. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 1994;36:351-356.
54. Arndt TL, Stodgell CJ, Rodier PM. The teratology of autism. Int J DevNeurosci 2005;23:189-199.
55. Bandim JM, Ventura LO, Miller MT, et al. Autism and Möbius sequence: an exploratory study of children in northeastern Brazil. Arq Neuropsiquiatr 2003; 61 (2A) : 181-185.
56. Moore SJ, Turnpenny P, Quinn A, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 2000;37:489-497. (Pubitemid 30428234)
57. Snow WM, Hartle K, Ivanco TL. Altered morphology of motor cortex neurons in the VPA rat model of autism. Dev Psychobiol 2008;50:633-639. Report from a study using the valproic-acid rat model for autism. The study used the valproic-acid model to examine brain development and developmental injuries, possibly related to autism. (Pubitemid 352748855)
58. Chess S. Autism in children with congenital rubella. J Autism Child Schizophr 1971;1:33-47.
59. Levin ED, Addy N, Nakajima A, et al. Persistent behavioural consequences of neonatal chloropyrifos exposures in rats. Brain Res Dev Brain Res 2001;130:83-89. (Pubitemid 32830975)
60. Engel SM, Berkowitz GS, Barr DB, et al. Prenatal organophosphate metabolite and organochlorine levels and performance on the Brazelton Neonatal Behavioral Assessment Scale in a multiethnic pregnancy cohort. Am J Epidemiol 2007;165:1397-1404.
61. Young JG, Eskenazi B, Gladstone EA, et al. Association between in utero organophosphate pesticide exposure and abnormal reflexes in neonates. Neurotoxicology 2005;26:199-209. (Pubitemid 40248438)
62. Rauh VA, Garfinkel R, Perera FP, et al. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics 2006; 118: e1845-e1859. (Pubitemid 46397562)
63. Miller MT, Stromland K, Ventura L, et al. Autism associated with conditions characterized by developmental errors in early embryogenesis: a mini review. Int J Dev Neurosci 2005;23:201-219. (Pubitemid 40313553)
64. Engel SM, Zhu C, Berkowitz GS, et al. Prenatal phthalates exposure and performance on the Neonatal Behavioral Assessment Scale in a multiethnic birth cohort. Neurotoxicology 2009. doi: 10.1016/j.neuro.2009.04.001. A study examining relationship between prenatal maternal urinary concentrations of phthalate metabolites and neonatal behaviour in a multiethnic birth cohort. This study is of particular interest as it is the first to report an association between prenatal phthalate exposure and neurological effects in humans and animals.
65. Baker JP. Mercury, vaccines, and autism. One controversy, three histories. Am J Public Health 2008;98:244-253.
66. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, nonspecific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-641. (Pubitemid 28098447)
67. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999;353:2026-2029. (Pubitemid 29271747)
68. Kaye JA, del Mar. Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. Br Med J 2001;322:460-463. (Pubitemid 32238805)
69. Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization coverage in California. J Am Med Assoc 2001;285:1183-1185. (Pubitemid 32198484)
70. Honda H, Shimizu Y, Rutter M. No effect of MMR withdrawal on the incidence of autism: atotal population study. J Child Psychol Psychiatry 2005;46:572-579. (Pubitemid 40778959)
71. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002;347:1477-1482. (Pubitemid 35257586)
72. Mäkelä A, Nuorti JP, Peltola H. Neurologic disorders after measles-mumpsrubella vaccination. Pediatrics 2002;110:957-963.
73. Heron J, Golding J, and the ALSPAC Study Team. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatrics 2004;114:577-583. (Pubitemid 41529509)
74. Thompson WW, Price C, Goodson B, et al., Vaccine Safety Datalink Team. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 2007;357:1281-1292.
75. Offit PA. Autism's false prophets: bad science, risky medicine, and the search for a cure. New York, NY: Columbia University Press; 2008.
76. Hertz-Picciotto I, Croen LA, Hansen R, et al. The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect 2006;114:1119-1125. (Pubitemid 44018911)
77. Slotkin TA, MacKillop EA, Ryde IT, et al. Screening for developmental neurotoxicity using PC12 cells: comparisons of organophosphates with carbamate, an organochlorine, and divalent nickel. Environ Health Perspect 2007;115:93-101.
78. Schmidt C. Tox21: new dimensions of toxicity testing. Environ Health Perspect 2009; A348-A353. A study describing the Tox21 partnership involving the National Toxicology Program, the NIH Chemical Genomics Center, and the US Environmental Protection Agency. This study discusses the goals of this partnership;to identify new mechanisms of chemical activity in cells;to prioritize evaluations of untested chemicals;and to develop predictive models for the human response to toxicants.
79. Makris SL, Raffaele K, Allen S, et al. A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environ Health Perspect 2009;117:17-25.
80. Hass U. Current status of developmental neurotoxicity: regulatory view. Toxicol Lett 2003; 140 141: 155-159. (Pubitemid 36378934)
81. Landrigan PJ, Kimmel CA, Correa A, Eskenazi B. Children's health and the environment: public health issues and challenges for risk assessment. Environ Health Perspect 2003;112:257-265. (Pubitemid 38195835)
82. Landrigan PJ, Trasande L, Thorpe LE, et al. The National Children's study: a 21-year prospective study of 100, 000 American children. Pediatrics 2006;118:2173-2186. (Pubitemid 46393701)